---
document_datetime: 2025-05-13 16:20:32
document_pages: 22
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/tobi-podhaler-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: tobi-podhaler-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 12.2164663
conversion_datetime: 2025-12-26 19:03:02.531476
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## TOBI Podhaler

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                   |
|----------------------|----------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/9315/ 202406   | Periodic Safety Update EU Single assessment - tobramycin (inhalation powder, capsules) | 27/02/2025                          | 23/04/2025                                  | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/9315/202406. |
| IB/0069              | B.IV.z - Quality change - Change in Medical Devices - Other variation                  | 05/02/2025                          | n/a                                         |                                  |                                                                                                                                           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IA/0068   | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                 | 17/12/2024   | n/a   |           |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------|
| IA/0067/G | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test | 09/12/2024   | n/a   | procedure |
| IA/0066   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 05/11/2024   | n/a   |           |
| IA/0064/G | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished                                                                                             | 21/08/2024   | n/a   |           |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | - Minor changes to an approved test                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |            |            |    | product procedure   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----|---------------------|
| N/0063    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 05/08/2024 | 23/04/2025 | PL |                     |
| IB/0062/G | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.II.c.1.c - Change in the specification parameters and/or limits of an excipient - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method A.7 - Administrative change - Deletion of manufacturing sites B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new | 18/06/2024 | n/a        |    |                     |

<div style=\"page-break-after: always\"></div>

| corresponding test method B.II.c.1.a - Change in the and/or limits of an excipient specification limits B.II.c.1.a - Change in the and/or limits of an excipient specification limits B.II.c.2.a - Change in test - Minor changes to an approved B.II.c.2.d - Change in test - Other changes to a test replacement or addition) B.II.b.5.z - Change to applied during the manufacture product - Other variation B.II.b.5.z - Change to applied during the manufacture product - Other variation B.II.b.3.z - Change in the the finished or intermediate B.II.b.3.a - Change in the the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the the finished or intermediate in the manufacturing process B.II.b.1.e - Replacement manufacturing site for manufacturing operation(s) release, batch control,   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| IB/0061/G   | This was an application for a group of variations.                                                                                                                                     | 13/12/2023   | n/a   |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|
| IB/0060     | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting | 12/09/2023   | n/a   |

<div style=\"page-break-after: always\"></div>

|           | material/intermediate                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |     |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| II/0057/G | This was an application for a group of variations. B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.I.z - Quality change - Active substance - Other variation B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.1.f - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Change outside the approved specifications limits range for the AS B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting | 31/08/2023 | n/a |

<div style=\"page-break-after: always\"></div>

|           | specification parameter (e.g. deletion of an obsolete parameter) B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                     |            |            |                       | significant   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|---------------|
| WS/2481   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                          | 13/07/2023 | 20/06/2024 | SmPC, Annex II and PL |               |
| IA/0059/G | an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                      | 28/06/2023 | n/a        |                       | This was      |
| II/0053   | Submission of an updated RMP version 8.1 following the request by PRAC in the AR for PSUSA/00009315/202106 in order to update it based on the guidance provided in the GVP and to remove the safety concerns as well as to reflect the finalization of study CTBM100C2407 and the transfer of ownership. | 14/04/2023 | n/a        |                       |               |

<div style=\"page-break-after: always\"></div>

|                    | C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of change(s) which require to be further substantiated by new additional data to be submitted by the MAH where significant assessment is required                                                                                                             |            |            |                        |                                   |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| T/0056             | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                        | 08/03/2023 | 31/03/2023 | SmPC, Labelling and PL |                                   |
| IA/0055            | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                               | 13/02/2023 | n/a        |                        |                                   |
| IA/0054/G          | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) | 04/10/2022 | n/a        |                        |                                   |
| N/0052             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                           | 13/05/2022 | 31/03/2023 | PL                     |                                   |
| PSUSA/9315/ 202106 | Periodic Safety Update EU Single assessment - tobramycin (inhalation powder, capsules)                                                                                                                                                                                                                                                                                                                     | 10/02/2022 | n/a        |                        | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| IA/0050/G   | This was an application for a group of variations. B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure   | 06/08/2021   | n/a        |             |                                                                                          |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|------------------------------------------------------------------------------------------|
| IB/0049     | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 22/07/2021   | 22/11/2021 | SmPC and PL | To extend the shelf-life of the finished product as packaged for sale from 3 to 4 years. |
| IB/0048     | B.II.z - Quality change - Finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 30/06/2021   | n/a        |             |                                                                                          |
| IA/0047/G   | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where                                                                                                                                                                                                                                                                                       | 01/03/2021   | n/a        |             |                                                                                          |

<div style=\"page-break-after: always\"></div>

|             | batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |            |                 |                         |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-------------------------|
| IAIN/0046/G | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites                                                                                                                                                                                                                                                                                                                                                   | 08/12/2020 | 22/11/2021 | Annex II and PL | (excluding manufacturer |
| IA/0045/G   | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.7 - Administrative change - Deletion of manufacturing sites B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - | 12/10/2020 | n/a        |                 |                         |

<div style=\"page-break-after: always\"></div>

|           | of a site where batch takes place                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |            |            |                       | Replacement/addition control/testing   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|----------------------------------------|
| IB/0044/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.z - Quality change - Finished product - Other variation B.II.a.1.a - Change or addition of imprints, bossing or other markings including replacement, or addition of inks used for product marking - Changes in markings                                                                                                                                                                                                                                                                           | 04/09/2020 | 22/11/2021 | SmPC, Annex II and PL | imprints, bossing or other             |
| IB/0043/G | This was an application for a group of variations. B.II.z - Quality change - Finished product - Other variation B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.II.c.1.c - Change in the specification parameters and/or limits of an excipient - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.II.c.2.d - Change in test procedure for an excipient - Other changes to a test procedure (including replacement or addition) | 13/07/2020 | n/a        |                       |                                        |
| IAIN/0042 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP -                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 16/08/2019 | 27/07/2020 | Annex II and          |                                        |

<div style=\"page-break-after: always\"></div>

|           | or addition of a manufacturer for importation and/or batch release - including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |            | PL                     | Replacement responsible Not   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------|
| T/0041    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 31/05/2019 | 28/06/2019 | SmPC, Labelling and PL |                               |
| IA/0040/G | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test | 29/05/2019 | n/a        |                        | procedure                     |
| IA/0039/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 15/03/2019 | n/a        |                        | manufacturing                 |

<div style=\"page-break-after: always\"></div>

|                    | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |            |                        |                                                                                                                           |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|---------------------------------------------------------------------------------------------------------------------------|
| PSUSA/9315/ 201806 | Periodic Safety Update EU Single assessment - tobramycin (inhalation powder, capsules)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 14/02/2019 | n/a        |                        | PRAC Recommendation - maintenance                                                                                         |
| IA/0037            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 23/08/2018 | 28/06/2019 | Labelling and PL       |                                                                                                                           |
| T/0036             | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 20/03/2018 | 23/04/2018 | SmPC, Labelling and PL |                                                                                                                           |
| IA/0035/G          | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where | 16/05/2017 | n/a        |                        |                                                                                                                           |
| R/0034             | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 17/12/2015 | 18/02/2016 | SmPC and Annex II      | Based on the review of the available information the CHMP is of the opinion that the quality, the safety and the efficacy |

<div style=\"page-break-after: always\"></div>

|                    |                                                                                                                                                                                                                                                                                            |            |            |             | of this medicinal product continues to be adequately and sufficiently demonstrated and therefore considers that the benefit/risk profile of TOBI Podhaler continues to be favourable. The CHMP is of the opinion that the renewal can be granted with unlimited validity.   |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/9315/ 201506 | Periodic Safety Update EU Single assessment - tobramycin (inhalation powder, capsules)                                                                                                                                                                                                     | 14/01/2016 | n/a        |             | PRAC Recommendation - maintenance                                                                                                                                                                                                                                           |
| II/0030            | Update of section 4.8 of the SmPC to add the new ADRs malaise and sputum discoloured based on reports from post-marketing experience. The PL is updated accordingly. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data     | 29/10/2015 | 18/02/2016 | SmPC and PL |                                                                                                                                                                                                                                                                             |
| IB/0032/G          | This was an application for a group of variations. B.II.z - Quality change - Finished product - Other variation B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place | 10/08/2015 | n/a        |             |                                                                                                                                                                                                                                                                             |
| IA/0031            | B.II.c.1.a - Change in the specification parameters and/or limits of an excipient - Tightening of specification limits                                                                                                                                                                     | 03/06/2015 | n/a        |             |                                                                                                                                                                                                                                                                             |
| IA/0029            | B.II.c.1.a - Change in the specification parameters                                                                                                                                                                                                                                        | 24/04/2015 | n/a        |             |                                                                                                                                                                                                                                                                             |

<div style=\"page-break-after: always\"></div>

|             | and/or limits of an excipient - Tightening of specification limits                                                                                                                                                                                                                                                                                                                                                                                                                                                         |            |            |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUV/0026   | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 09/01/2015 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| II/0027/G   | This was an application for a group of variations. Update of sections 4.2, 4.4 and 4.8 of the SmPC in order to reflect data from study CTBM100C2401 (in fulfilment of MEA 10). Update of the RMP to reflect the study conclusion. In addition, update of the product information to reflect the change of address of the MAH. A.1 - Administrative change - Change in the name and/or address of the MAH C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 20/11/2014 | 11/02/2015 | SmPC, Labelling and PL | In this variation application the MAH submitted the clinical study report from study CTBM100C2401, 'A single arm, open label, multicentre, Phase IV trial to assess long-term safety of tobramycin inhalation powder (TIP) in patients with Cystic Fibrosis'. Study CTBM100C2401 was conducted as a post-authorization measure (PAM) for TOBI Podhaler with the aim of addressing the need for long-term data. The CHMP concluded that the newly submitted data on safety provided by the MAH are consistent with the known safety profile of the product and are considered not to change the overall benefit/risk of TOBI Podhaler. The MAH proposal to remove the statement that long-term data are not available for TOBI Podhaler in sections 4.2, 4.4 and 4.8 of the SmPC and relevant section of the package |
| IAIN/0028/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                       | 30/10/2014 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

<div style=\"page-break-after: always\"></div>

|           | B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place      |            |            |      |                                   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-----------------------------------|
| IB/0025   | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                      | 26/09/2014 | n/a        |      |                                   |
| II/0023   | Minor change to the manufacturing process of the finished product; to add an alternative batch size of the finished product. B.II.b.4.d - Change in the batch size (including batch size ranges) of the finished product - The change relates to all other pharmaceutical forms manufactured by complex manufacturing processes | 25/09/2014 | n/a        |      |                                   |
| IAIN/0024 | C.I.3.a - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Implementation of wording agreed by the competent authority                                                                                      | 04/08/2014 | 11/02/2015 | SmPC |                                   |
| PSUV/0021 | Periodic Safety Update                                                                                                                                                                                                                                                                                                          | 10/07/2014 | n/a        |      | PRAC Recommendation - maintenance |
| IA/0022   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                     | 31/03/2014 | n/a        |      |                                   |

<div style=\"page-break-after: always\"></div>

| II/0020   | Update of section 4.5 of the Tobi Podhaler SmPC to provide clarification on the concomitant use with intravenous mannitol. The PL was updated accordingly. The MAH took the opportunity to implement revisions in the PL previously agreed with the CHMP. Furthermore, the PI is being brought in line with the latest QRD template version 9.0. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance   | 23/01/2014   | 11/02/2015   | SmPC, Annex II, Labelling and PL   | This variation was submitted to supplement the existing information in section 4.5 of the Tobi Podhaler SmPC regarding the concomitant use with mannitol by clarifying that it refers to intravenous mannitol and not to mannitol for inhalation. The PL was updated accordingly and was complemented by the implementation of a wording, previously agreed with the CHMP in the 'Instructions for use' section, containing more clear instructions on the correct piercing orientation in order to improve the correct handling of the device during the piercing step.   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUV/0017 | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                                                          | 09/01/2014   | n/a          |                                    | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| II/0019   | Update of section 4.8 of the SmPC in order to change the frequency of the adverse drug reaction 'aphonia' from \"not known\" to \"common\", following a cumulative search of clinical data and post-marketing sources. The Package Leaflet is updated accordingly. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                | 18/12/2013   | 11/02/2015   | SmPC and PL                        | Five completed clinical study reports have been examined with a focus on 'aphonia' adverse event reports. A cumulative search of clinical data and post-marketing sources was also conducted for the adverse drug reaction 'aphonia'. Based on the assessment of these data, the frequency of 'aphonia' was updated to 'common' in the Tobi Podhaler product information.                                                                                                                                                                                                  |
| IA/0018/G | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test                                                                                                                                                                                              | 24/10/2013   | n/a          |                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|           | procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure   |            |            |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0016   | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                      | 02/10/2013 | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| PSUV/0015 | Periodic Safety Update                                                                                                                                                                                                                                                                                                                             | 25/07/2013 | 24/09/2013 | SmPC and PL | During the reviewed period, 1 new case of aphonia was reported. A total of three cases are available in Eudravigilance. The Marketing Authorisation Holder was requested to update the Product Information to include the adverse event 'aphonia', because:  cases detailing the adverse event aphonia with a time to onset compatible with a causal relationship between aphonia and TOBI Podhaler have been reported,  aphonia might be a more severe form of dysphonia which is listed according to the currently approved SmPC and the adverse event might be related to the active substance and is listed for tobramycin nebuliser solution TOBI 300 mg/5 ml (UK/H/0361/001). Otherwise no new (potential) safety issue has been identified. In view of available data regarding aphonia the PRAC considered that changes to the product information were |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                |            |            |                 | warranted. The CHMP agrees with the scientific conclusions made by the PRAC.   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|--------------------------------------------------------------------------------|
| IB/0014   | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                     | 25/06/2013 | n/a        |                 |                                                                                |
| IB/0013   | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                     | 06/03/2013 | n/a        |                 |                                                                                |
| IAIN/0012 | B.II.b.2.b.1 - Change to batch release arrangements and quality control testing of the FP - Not including batch control/testing                                                                                                                                                                                                                                | 18/01/2013 | 24/09/2013 | Annex II and PL |                                                                                |
| IG/0248   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                 | 17/12/2012 | n/a        |                 |                                                                                |
| IA/0009/G | This was an application for a group of variations. B.III.1.a.2 - Submission of a new or updated Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites | 28/11/2012 | n/a        |                 |                                                                                |
| IA/0008/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                             | 10/09/2012 | n/a        |                 |                                                                                |

<div style=\"page-break-after: always\"></div>

|           | B.III.1.a.2 - Submission of a new or updated Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier                                                    |            |     |           |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------|
| IG/0209/G | This was an application for a group of variations. C.I.9.b - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the contact details of the QPPV C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of pharmacovigilance system          | 17/08/2012 | n/a | the       |
| IA/0006   | A.4 - Administrative change - Change in the name and/or address of a manufacturer or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS                                                                                                                                                                                         | 10/08/2012 | n/a |           |
| IB/0004/G | This was an application for a group of variations. B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test | 20/06/2012 | n/a | procedure |

<div style=\"page-break-after: always\"></div>

|           | B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation B.II.c.1.z - Change in the specification parameters and/or limits of an excipient - Other variation                                                                                                                                             |            |     |                                 |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|---------------------------------|
| IB/0005   | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                                                                                                                     | 14/06/2012 | n/a |                                 |
|           | This was an application for a group of variations. C.I.9.e - Changes to an existing pharmacovigilance system as described in the DDPS - Changes in the major contractual arrangements with other persons or organisations involved in the fulfilment of pharmacovigilance obligations and described in the DD C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of | 22/02/2012 | n/a | IG/0148/G the pharmacovigilance |
| IA/0002/G | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding manufacturer for batch release) A.7 - Administrative change - Deletion of sites                                                                                                                                                                              | 15/12/2011 | n/a | manufacturing                   |

<div style=\"page-break-after: always\"></div>

| IG/0109   | C.I.9.i - Changes to an existing pharmacovigilance described in the DDPS - Change(s) to a   | 30/09/2011   | n/a   | Annex II   | system as DDPS following the relation to another MAH   |
|-----------|---------------------------------------------------------------------------------------------|--------------|-------|------------|--------------------------------------------------------|